Genetische Diagnostik vor assistierter Reproduktion – Empfehlungen der neuen S2k-Leitlinie 2019

https://www.awmf.org/leitlinien/detail/ll/015-085.html, zugegriffen 15. Dez. 2019

Barratt CLR, Björndahl L, DeJonghe CJ et al (2017) The diagnosis of male infertility: an analysis of the evidence to support the development of global WHO guidance-challenges and future research opportunities. Hum Reprod Update 23:660–680

Krausz C, Hoefsloot L, Simoni M, Tüttelmann F (2014) European Academy of Andrology; European Molecular Genetics Quality Network. EAA/EMQN best practice guidelines for molecular diagnosis of Y‑chromosomal microdeletions: state-of-the-art 2013. Andrology 2:5–19

Stouffs K, Vloeberghs V, Gheldof A et al (2017) Are AZFb deletions always incompatible with sperm production? Andrology 5:691–694

Tüttelmann F, Gromoll J, Kliesch S (2008) Genetik der männlichen Infertilität. Urologe 47:1561–1567

Dul EC, Van Ravenswaaij-Arts CMA, Groen H et al (2010) Who should be screened for chromosomal abnormalities before ICSI treatment? Hum Reprod 25:2673–2677

Gekas J, Thepot F, Turleau C et al (2001) Chromosomal factors of infertility in candidate couples for ICSI: an equal risk of constitutional aberrations in women and men. Hum Reprod 16:82–90

Donker RB, Vloeberghs V, Groen H, Tournaye H et al (2017) Chromosomal abnormalities in 1663 infertile men with azoospermia: the clinical consequences. Hum Reprod 32:2574–2580

Harper JC, Aittomäkki K, Borry P et al (2018) Recent developments in genetics and medically assisted reproduction: from research to clinical applications. Eur J Hum Genet 26:12–33

Tüttelmann F, Ruckert C, Röpke A et al (2018) Disorders of spermatogenesis: perspectives for novel genetic diagnostics after 20 years of unchanged routine. medgen 30:12–20

Schwarzer JU, Schwarz M (2012) Significance of CFTR gene mutations in patients with congenital aplasia of vas deferens with special regard to renal aplasia. Andrologia 44:305–307

Patat O, Pagin A, Siegfried A et al (2016) Truncating mutations in the adhesion G protein-coupled receptor G2 gene ADGRG2 cause an X‑linked congenital bilateral absence of vas deferens. Am J Hum Genet 99:437–442

Tüttelmann F, Gromoll J (2010) Novel genetic aspects of Klinefelter’s syndrome. Mol Hum Reprod 16:386–395

Nieschlag E (2013) Klinefelter syndrome: the commonest form of hypogonadism, but often overlooked or untreated. Dtsch Arztebl Int 110:347–353

Corona G, Pizzocaro A, Lanfranco F et al (2017) Sperm recovery and ICSI outcomes in Klinefelter syndrome: a systematic review and meta-analysis. Hum Reprod Update 23:265–275

Bonomi M, Vezzoli V, Krausz C et al (2018) Characteristics of a nationwide cohort of patients presenting with isolated hypogonadotropic hypogonadism (IHH). Eur J Endocrinol 178:23–32

Boehm U, Bouloux P‑M, Dattani MT et al (2015) European Consensus Statement on congenital hypogonadotropic hypogonadism—pathogenesis, diagnosis and treatment. Nat Rev Endocrinol 11:547–564

Franasiak JM, Forman EJ, Hong KH et al (2014) The nature of aneuploidy with increasing age of the female partner: a review of 15,169 consecutive trophectoderm biopsies evaluated with comprehensive chromosomal screening. Fertil Steril 101:656–663.e1

Jahrbuch 2016 Deutsches IVF Register (2017) J Reprod Endokrin 6:275–305

Qin Y, Jiao X, Simpson JL et al (2015) Genetics of primary ovarian insufficiency: new developments and opportunities. Hum Reprod Update 21:787–808

Pasquino AM, Passeri F, Pucarelli I et al (1997) Spontaneous pubertal development in Turner’s syndrome. J Clin Endocrinol Metab 82:1810–1813

Homer L, Le Martelot MT, Morel F et al (2010) 45,X/46,XX mosaicism below 30 % of aneuploidy: clinical implications in adult women from a reproductive medicine unit. Eur J Endocrinol 162:617–623

Grynberg M, Bidet M, Bernard J et al (2016) Fertility preservation in Turner syndrome. Fertil Steril 105:13–19

Shankar RK, Backeljauw PF (2018) Current best practice in the management of Turner syndrome. Ther Adv Endocrinol Metab 9:33–40

Mercadal AB, Imbert R, Demeestere I et al (2011) Pregnancy outcome after oocyte donation in patients with Turner’s syndrome and partial X monosomy. Hum Reprod 26:2061–2068

Tartaglia NR, Howell S, Sutherland A et al (2010) A review of trisomy X (47,XXX). Orph J Rare Dis 5:8

Bagni C, Tassone F, Neri G et al (2012) Fragile X syndrome: causes, diagnosis, mechanisms, and therapeutics. J Clin Invest 122(12):4314–4322

Nelson LM (2009) Primary ovarian insufficiency. N Eng J Med 360:606–614

Layman LC (2013) The genetic basis of female reproductive disorders: etiology and clinical testing. Mol Cell Endocrinol 370:138–148

http://www.awmf.org/leitlinien/detail/ll/174-013.html, zugegriffen 15. Dez. 2019

Riccaboni A, Lalatta F, Caliari I et al (2008) Genetic screening in 2,710 infertile candidate couples for assisted reproductive techniques: results of application of Italian guidelines for the appropriate use of genetic tests. Fertil Steril 89:800–808

Foresta C, Ferlin A, Gianaroli L et al (2002) Guidelines for the appropriate use of genetic tests in infertile couples. Eur J Hum Genet 10:303–312

ACOG Committee on Obstetric Practice, ACOG Committee on Gynecologic Practice, ACOG Committee on Genetics. (2005) ACOG Committee Opinion #324: Perinatal risks associated with assisted reproductive technology. Obstet Gynecol 106:1143–1146

https://www.nice.org.uk/guidance/cg156, zugegriffen 15. Dez. 2019

Okun N, Sierra S (2014) Pregnancy outcomes after assisted human reproduction. J Obstet Gynaecol Can 36:64–83

Practice Committee of the American Society for Reproductive Medicine (2015) Diagnostic evaluation of the infertile male: a committee opinion. Fertil Steril 103:e18–e25